Cytocom, Inc.
CBLI · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $42,768 | $6,802 | $11,407 | $44,881 |
| - Cash | $1,946 | $1,126 | $3,617 | $4,231 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $40,822 | $5,675 | $7,790 | $40,650 |
| Revenue | $263 | $1,113 | $1,138 | $1,948 |
| % Growth | -76.4% | -2.2% | -41.6% | – |
| Gross Profit | $263 | $1,113 | $1,138 | $1,948 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$2,387 | -$2,633 | -$3,594 | -$9,685 |
| % Margin | -907.8% | -236.5% | -315.7% | -497.1% |
| Net Income | -$2,398 | -$2,647 | -$3,612 | -$9,706 |
| % Margin | -912.2% | -237.7% | -317.3% | -498.2% |
| EPS Diluted | -0.19 | -0.23 | -0.32 | -0.87 |
| % Growth | 17.4% | 28.1% | 63.2% | – |
| Operating Cash Flow | -$2,373 | -$2,663 | -$4,613 | -$6,611 |
| Capital Expenditures | $0 | -$2 | -$28 | -$4 |
| Free Cash Flow | -$2,373 | -$2,665 | -$4,641 | -$6,616 |